Abstract. Certain epithelial cells synthesize the polymeric immunoglobulin receptor (plgR) to transport immunoglobulins (Igs) A and M into external secretions. In polarized epithelia, newly synthesized receptor is first delivered to the basolateral plasma membrane and is then, after binding the Ig, transcytosed to the apical plasma membrane, where the receptor-ligand complex is released by proteolytic cleavage. In a previous work (Ikonen et al., 1993) , we implied the existence of a dendro-axonal transcytotic pathway for the rabbit plgR expressed in hippocampal neurons via the Semliki Forest Virus (SFV) expression system. By labeling surfaceexposed plgR in live neuronal cells, we now show (a) internalization of the receptor from the dendritic plasma membrane to the dendritic early endosomes, (b) redistribution of the receptor from the dendritic to the axonal domain, (c) inhibition of this movement by brefeldin A (BFA) and (d) stimulation by the activation of protein kinase C (PKC) via phorbol myristate acetate (PMA). In addition, we show that a mutant form of the receptor lacking the epithelial basolateral sorting signal is directly delivered to the axonal domain of hippocampal neurons. Although this mutant is internalized into early endosomes, no transcytosis to the dendrites could be observed. In epithelial Madin-Darby Canine Kidney (MDCK) cells, the mutant receptor could also be internalized into basolaterally derived early endosomes. These results suggest the existence of a dendro-axonal transcytotic pathway in neuronal cells which shares similarities with the basolateral to apical transcytosis in epithelial cells and constitute the basis for the future analysis of its physiological role.
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I
N polarized cells, such as epithelial cells and neurons, the plasma membrane is divided into two domains that differ morphologically, functionally and biochemically. In most epithelia, and possibly also in neurons, the asymmetric organization of the plasma membrane is generated by the sorting of membrane constituents into distinct vesicles in the TGN (for reviews see Rodriquez-Boulan and Powell, 1992; de Hoop and Dotti, 1993; Craig and Banker, 1994) . Besides direct sorting, certain polarized cells generate membrane asymmetry by another vesicular pathway called transcytosis (Bartles et al., 1987 ; for reviews see Rodman et al., 1990; Nelson, 1992; Mostov et al., 1992) . Transcytosis is also used to transport substances from one domain to the other. This includes the transepithelial transport of transferrin (Soda and Tavassoli, 1984; Friden et al., 1991) , low density lipoprotein (Hashida et al., 1986) , serum albumin (Ghitescu and Bendayan, 1992) , insulin (King and Johnson, 1985; Pardridge, 1991) , epidermal growth factor (Br~indli et al., 1991; Gonnella et al., 1987) , nerve growth factor (Siminoski et al., 1986) , thyroglobulin (Herzog, 1983) , and antibodies (Kraehenbuhl and Neutra, 1992; Hunziker and Mellman, 1989; Sooranna and Contractor, 1991) .
The best characterized transcytotic molecule is the polymeric immunoglobulin receptor (pIgR) t. The pIgR has a large extracellular ligand-binding domain, called the secretory component (SC), a single transmembrane domain and an intracellular cytoplasmic tail of 103 amino acids (Mostov et al., 1984) . In the polarized kidney epithelial cell line MDCK newly synthesized pIgR is sorted in the TGN to the basolateral plasma membrane where it can bind its ligand, dimeric IgA (dIgA). The receptor-ligand complexes, as well as unoccupied receptors are efficiently internalized into the basolateral early endosomes. Here, both the occupied and the unoccupied receptors are sorted into transcytotic vesicles, although some receptors recycle to the basolateral plasma membrane Breitfeld et al., 1989) . Transcytotic vesicles are delivered to apical endocytic structures and from there to the apical plasma membrane (Apodaca et al., 1994; Cardone et al., 1994; Barroso and Sztul, 1994) . Either during its intracellular transport or upon insertion into the plasma membrane, the SC is proteolytically cleaved by a leupeptin-sensitive protease and released in complex with the bound ligand .
Several signals have been identified in the amino acid sequence of the receptor that regulate its complex intracellular routing. A sequence of 14 amino acids (from amino acid 655 to 668, bearing the sequence RHRRNV-DRVSICSY) in the cytoplasmic tail directs the receptor to the basolateral plasma membrane (Casanova et al., 1991) . Deletion of this basolateral-sorting signal results in direct transport of the receptor to the apical plasma membrane. Two tyrosines present at positions 668 and 734 in the cytoplasmic tail mediate endocytosis, although mutating tyrosine 734 affects endocytosis more than mutations in tyrosine 668 . Transcytosis is regulated by various mechanisms. Although the unoccupied receptor is able to transcytose, transcytosis is stimulated by the binding of its natural ligand dlgA . Phosphorylation of serine 664 and 726 enhances transcytosis (Okamoto et al., 1994; Casanova et al., 1990; Hirt et al., 1993) . Although the identity of the kinases is unknown, the involvement of protein kinase A and C in transcytosis has been demonstrated (Cardone et al., 1994; Hansen and Casanova, 1994) . Transcytosis is also controlled by heterotrimeric G proteins that have been shown to modulate many steps of the endocytic and exocytic traffic Mostov, 1992, 1993; Barroso and Sztul, 1994; Hansen and Casanova, 1994) . Finally it has been demonstrated that the drug brefeldin A (BFA) inhibits transcytosis, probably by interfering with the sorting of pfgR into transcytotic vesicles in the basolateral early endosomes (Hunziker et al., 1991 (Hunziker et al., , 1992 .
In our previous work we showed the direct delivery of the wild-type pIgR to the dendrites of cultured hippocampal neurons and its subsequent appearance in the axons upon addition of dlgA (Ikonen et al., 1993) . In the present paper we describe the direct sorting of the wild-type plgR to the dendritic membrane, and by following the movement of the antibody-labeled receptor in living cells, we demonstrate its transcytotic movement to the axonal domain, This transcytotic movement is inhibited by BFA and stimulated by PMA which activates PKC. We also show that, in contrast to the wild-type receptor, a mutant form of the receptor lacking the epithelial basolateral targeting signal (Casanova et al., 1991) is delivered directly to the axons.
Materials and Methods

Chemicals
Phorbol 12-myristate 13-acetate (PMA), also called 12-O-tetradecanoylphorbol 13-acetate (TPA), was stored as a 0.1 mg/ml stock solution in ethanol at -20°C and was used at a final concentration of 2 ~M. Brefeldin A was stored as a stock solution of 5 mg/ml in ethanol, and used at 10 p.g/ml. Leupeptine was dissolved in water at 50 mg/ml, neutralized, and stored at -20°C until use at a concentration of 100 sg/ml. All these chemicals were purchased from Sigma (Sigma Chem. Co., St. Louis, MO).
Antibodies
The monoclonal antibody against the membrane and cytoplasmic domain of the rabbit plgR (SC166) has been described (Ktihn and Kraehenbuhl, 1983; Solari et al., 1985) . A goat polyclonal antibody against the secretory component of the rabbit plgR was obtained from Cooper Biomedical (Malvern, PA). The polyclonal antibody against MAP 2 was generously provided by Dr. Diez-Guerra, Centro de Biologia Molecular (CBM) (Madrid, Spain).
DNA Constructs and Production of Recombinant Semliki Forest Virus
The cloning of the pSFVI-pIgR wild-type and the preparation of recombinant SFV has been described (Ikonen et al., 1993; Olkkonen et al., 1993) . To obtain the pIgR A655-668 mutant, the cDNA encoding wild-type plgR (Mostov et al., 1984) was subcloned from plasmid pCB6 (Brown et al., 1989) into Bluescript KS, resulting in the plasmid KS-pIgR in which the 5'end of the pIgR gene faces the T3 promoter. This plasmid was amplified with the 5' mutagenic primer (5' GCC ATG GCC GTG GCC ATA GCC AGA GCC AGG ACA GAC ATT AGC ATG TCA GAC) and the 3' primer (5' GCT CCT CAA TCT CGA GGG TGC TC). The PCR product was digested with MscI and XbaI and ligated into the MscI and XbaIcut Bluescript KS-pIgR. The MscI site is in the pIgR transmembrane domain, XbaI in the Bluescript polylinker; this cloning procedure essentially exchanged the wild-type cytoplasmic tail for the mutagenized cytoplasmic tail. The region amplified by PCR was sequenced, pIgR A655-668 was excised with SpeI and EcoRV, made blunt ended with the Klenow fragment of DNA polymerase and cloned into the dephosphorylated SmaI-cut plasmid pSFV1 (Liljestr6m and Garoff, 1991) .
Detailed protocols on the preparation and application of recombinant SFVs in hippocampal neurons have been published (Liljestr/~m and Garoff, 1991; Olkkonen et al., 1993; de Hoop et al., 1994) .
Cell Culture and Infections
Primary cultures of rat hippocampal neurons were prepared as described (Goslin and Banker, 1991) . Cells were grown in N2 medium (Bottenstein and Sato, 1979) supplemented with 1 ng/ml basic fibroblast growth factor (Boehringer Mannheim Biochemica, Mannheim, Germany). Unless stated otherwise, neurons used had been cultured for 9-14 d (stage 5 cells; Dotti et al., 1988) . Hippocampal neurons were infected with recombinant SFV as described (de Hoop et al., 1994) . After 1 h infection, cells were incubated for 3-5 h to allow SFV-driven protein synthesis. In some experiments cycloheximide (Sigma Chem. Co.) was added (20 ~g/ml) during the last 2 h of expression.
MDCK cells expressing either wild-type (Hunziker et al., 1990; Mostov and Deitcher, 1986) or pIgR A655-668 (Casanova et al., 1991) under control of the CMV promoter were cultured at 37°C and 5% CO2 in MEM with 5% FCS, 2 mM glutamine, 100 U/ml penicillin, 100 p~g/ml streptomycin, and 0.25 mg/ml geneticin (G418; Gibco BRL Life Technologies Inc., Grand Island, NY) for cells expressing the mutant A655-668 or 0.25 mg/ml hygromycin B (Calbiochem-Behring, La Jolla, CA) for cells expressing wild-type pIgR.
Immunofluorescence
Neurons on coverslips were fixed with 4% paraformaldehyde in PBS for 20 min at room temperature followed by a 15-rain incubation in 50 mM NH4C1 in PBS to quench excess paraformaldehyde. Cells were permeabilized via graded ethanol series. Nonspecific binding sites were blocked by incubation in 2% bovine serum albumin, 2% FCS and 0.2% cold-water fish-skin gelatin (Sigma Chem. Co.) in water for 30 rain. The cells were then incubated with primary antibody for 1 h at room temperature and, after extensive washing with PBS, with species-specific secondary antibody (from Cappel, Durham, NC and from Dianova, Hamburg, Germany). The coverslips were mounted in Mowiol 4-88 (Calbiochem-Novabiochem Corp., La Jolla, CA) containing 2.5% DABCO (Sigma Chem. Co.) as an antibleaching agent and microscopy was performed with an Axiophot microscope (Zeiss, Oberkochen, Germany).
Filter-grown MDCK cells were fixed with 4% paraformaldehyde and permeabilized with saponin (0.025 % in PBS + containing 0.7% cold-water fish-skin gelatin) as described (Huber et al., 1993a) . Cells were mounted with spacers in 50% glycerol containing 2.5% DABCO and viewed with the European Molecular Biology Laboratory Confocal Microscope.
Identification and Quantitation of plgR Labeled Processes
To precisely determine the axonal or dendritic distribution of the wild-type or mutant receptor, low multiplicity of infection was used. In this way, very few cells per coverslip were infected and it was thus possible to unequivocably distinguish the origin, trajectory, and ending of the labeled processes. The identification of the processes as dendrites was done by double labeling with the dendritic marker MAP2 (Caceres et al., 1984) . A process was identified as axon by its lack of MAP2 staining. The distribution was classified into the following pattern: soma and dendrites, soma and axons, and soma and both axons and dendrites. Several coverslips from different experiments were examined by two independent observers, the number of infected cells and process distribution averaged and the standard deviation calculated. Significance was determined by student's t test.
Internalization Experiments
The internalization experiments in neurons were performed as follows: FITC-coupled polyclonal antibodies against the secretory component of the rabbit pIgR were dissolved 1:100 in N 2 medium. Coverslips with attached neurons were put on top of small droplets of prewarmed antibodycontaining medium during 20 min at 5% CO2 and 36.5°C. Cells were then washed with cold HBSS containing 0.2% BSA, fixed with 4% paraformaldehyde in PBS and processed for immunofluorescence. To label the early endocytic compartment of neurons, Lucifer yellow-CH (dilithium salt, Sigma Chem. Co.) was added to the medium at 10 mg/ml. Neurons were incubated in Lucifer yellow-containing medium for 20 min, followed by a thorough wash with ice cold HBSS containing 0.2% BSA, fixed with 4% paraformaldehyde and processed for immunofluorescence.
To label the pIgRs present in the early endocytic compartment of filtergrown MDCK cells, the antibody against the secretory component of the rabbit pIgR (dissolved 1:40 in MEM containing 0.05% BSA and 10 mM Hepes-NaOH, pH 7.3; MEM-BSA) was added to the medium and the cells were incubated on ice for 45 min. Unbound antibody was removed by a quick wash in ice-cold MEM-BSA. Then, the basolateral side of the cells was exposed to 10 mg/ml lucifer yellow-CH (5 min at 37°C in MEM-BSA) to allow internalization of surface-bound antibodies and the fluidphase ligand. Finally, the cells were thoroughly washed with ice-cold MEM-BSA, fixed with 4% paraformaldehyde and processed for immunofluorescence as described above.
Transcytosis Assay
Transcytosis of the pIgR in living cells was analyzed as follows: cells were infected for 1 h at 36.5°C, excess virus was removed and the cells were further incubated for 3 h in the presence of 100 p,g/ml leupeptin to prevent the proteolytic removal of the secretory component . At the end of the 3-h expression period, the coverslips were incubated on ice for 30 min in small drops (_+ 100 ~1) of air-MEM (MEM containing 4 mM NaHCO3, 10 mM Hepes, pH 7.3, 2 mM glutamine, 0.6% glucose, 110 izg/ml pyruvic acid) with 5% FCS, 100 ttg/ml leupeptin and 1:100 diluted FITC-conjugated anti-SC. Coverslips were subsequently washed in cold HBSS with 0.2% BSA and either fixed to examine the distribution of surface-bound antibody against the eetodomain (the secretory component) or transferred to prewarmed maintenance medium containing BFA (10 txg/ml) or PMA (2 I~M) or medium without additions for 20 min to 2 h at 36.5°C. Finally, the cells were fixed, washed, and mounted to examine the distribution of the anti-SC antibody by fluorescence microscopy.
Western Blot Analysis
Hippocampal neurons were plated directly onto polylysine-coated 6-cm culture dishes (Nunc, Roskilde, Denmark) at a density of 300,000-400,000 cells per dish and cultured for three days. 5 h after infection with approximately equal amounts of recombinant virus, carrying either the wild-type or A655-668 pIgR cDNA, the neurons were lysed (de Hoop et al., 1994) and the cell extracts were analyzed by Western blotting using the anti-CT monoclonal antibody SC166 (diluted 1:100), followed by ECL detection as recommended by the supplier (Amersham International, Buckinghamshire, England).
Results
Expression of the Polymeric Immunoglobulin Receptor in Hippocampal Neurons in Culture
In a previous work we showed by indirect immunofluorescence that infection of polarized hippocampal neurons in culture with recombinant SFV resulted in the appearance of the plgR in the dendrites and, to a lesser extent, also in axons. The axonal labeling was increased 2--4-fold upon addition of ligand (Ikonen et al., 1993) . The aim of the present work was to analyze the mechanisms of this transcytotic route and the sorting of the A655-668 mutant, which lacks a basolateral targeting signal.
We first examined by Western blot the SFV-driven expression (Liljestr6m and Garoff, 1991; Olkkonen et al., 1993) of wild-type and A655-668 mutant plgR in polarized hippocampal neurons in culture. In neurons expressing wild-type plgR, a band of ~120 kD was visible (Fig. 1, lane  2) agreeing with the molecular weight of endogenous plgR in liver (Sztul, 1992) . In neurons expressing the A655-668 plgR mutant (lane 3), a band with slightly higher electrophoretic mobility, due to the deletion, was observed. As expected, no expression was detected in control neurons and MDCK cells (lanes I and 4). The intensity of the 120-kD band differed slightly between neurons infected with truncated and wild-type pIgR. This is due to a difference in the efficiency of infection. The band of ~35 kD visible in MDCK cells expressing wild-type pIgR (arrow in lane 5) represents the cleaved cytoplasmic tail and membrane domain of the receptor (Kiihn and Kraehenbuhl, 1983; Solari et al., 1985) .
IntraceUular Distribution of Newly Synthesized Wild-Type and Mutant plgR
To analyze the routing of newly synthesized pIgR, fully polarized hippocampal neurons were infected with recombinant virus which express the pIgR and the distribution of the receptor was determined by immunofluorescence microscopy at 3 h postinfection. This was the earliest time point at which pIgR expression was detectable. The wildtype receptor (Fig. 2 B) was predominantly found in the somatodendritic region. Quantitative analysis revealed exclusive cell body and dendritic labeling in 85% of the cells (Fig. 3 A) . In the remaining cells (15%), the labeling was present in the cell body and both dendrites and axons. We did not find cells with cell body and axonal staining in the absence of dendritic labeling. This result indicates the direct delivery of the wild-type plgR from the cell body to the dendritic domain.
In contrast to the cells expressing wild-type plgR, the majority (64%) of the cells expressing the mutant plgR displayed cell body and axonal labeling (Fig. 2, D-F, Fig. 3 A). Occasionally, labeling'was also observed in the proximal, but not the distal, part of the dendrites. This labeling might correspond to receptor accumulated in the organelles of the secretory pathway which, in these cells, are found some distance into the dendrites (Krijnse-Locker, J., R. G. Parton, S. D. Fuller, G. Griffiths, and C. G. Dotti, axonal (Fig. 3 B) , a threefold increase in the number of cells with axonal labeling compared to that of 3 h postinfection (see above). Although not so dramatic, an increase (1.6-fold) in axonal labeling was still observed in the presence of cycloheximide during the last 2 h of the postinfection time (not shown), suggesting either a transcytotic redistribution of wild-type plgR from the dendritic to the axonal domain or missorting induced by the high expression obtained by the efficient viral expression system.
At long postinfection times (5 h), the percentage of cells expressing mutant plgR with exclusive axonal staining had decreased to one fifth, from 64% (3 h postinfection) to 13% (5 h postinfection) (Fig. 3 B) . This decrease in prevalent axonal staining was to a large extent prevented when cycloheximide was added during the last two hours of the postinfection period (data not shown), indicating that the dendritic labeling of the mutant pIgR might be predominantly caused by missorting due to overexpression rather than redistribution. manuscript submitted for publication). In 29% of the cells both the axons and the dendrites were labeled. The fact that in most infected cells the axon was the only labeled process suggests the direct axonal sorting of mutant plgR.
The Intracellular Distribution of Overexpressed plgR Changes at Long Postinfection Times
In epithelial cells, the pIgR transcytoses from the basolateral plasma membrane to the apical surface even in the absence of ligand . To determine whether or not the dendritically delivered pIgR would move to the
Overexpressed plgR Is Internalized into Early Endosomes
A prerequisite for the transcytosis of pIgR in epithelial cells is internalization in basolateral early endosomes where sorting into transcytotic vesicles takes place (Hunziker et al., 1992) . Hence, we analyzed next whether overexpressed wild-type pIgR would undergo internalization into the dendritic early endosomes. Infected neurons were incubated with FITC-labeled anti-SC antibody during the last 20 min of the postinfection period. After excess antibody was removed, the cells were fixed, permeabilized, labeled with anti-CT antibodies, and analyzed by immunofluorescence microscopy. Fig. 4 shows the results of such an experiment. The anti-SC antibody was found in vesicular structures present in the cell body and the dendrites (Fig. 4 C) which also labeled with the fluid-phase marker Lucifer yellow (not shown). The internalized antibody represented only a fraction of the total pool of wild-type pIgR as revealed by the anti-CT staining (Fig. 4 B) . No antibody internalization was observed in noninfected cells, showing that the labeling with the anti-SC antibody was not caused by nonspecific endocytosis.
The anti-SC antibody was also internalized in cells expressing the mutant pIgR. Fig. 4 F shows that the antibody accumulated intracellularly in vesicular structures. The total pool of the mutant receptor, as detected by the anti-CT antibody (Fig. 4 E) , seemed to colocalize almost completely with the internalized antibodies. In addition, an almost overlapping staining was found between the total pool of mutant pIgR and Lucifer yellow, that had been internalized for 20 rain (data not shown).
Considering that in MDCK cells more than 95% of the mutant pIgR is directly delivered to the apical surface (Casanova et al., 1991) , the intense endosomal labeling, present also in the dendritic domain of the hippocampal neurons, was somewhat unexpected. Since the studies in MDCK cells accounted exclusively for the mutant protein that had reached the surface, it was still possible that in In cells expressing the wild-type plgR, the internalized antibody can be seen in the dendrites and in the cell body (small arrows), but not in any of the axons in the field (large arrows). The mutant plgR is present in regularly shaped structures in both the axon (large arrows) as well as in the dendrites (small arrows). Bar represents 20 ~m. these cells the A655-668 pIgR was also present in the basolateral endosomes. To detect the plgR present in basolateral endosomes, MDCK cells expressing A655-668 plgR were incubated with anti-SC antibody and basolaterally added Lucifer yellow and processed for confocal immunofluorescence microscopy. We observed colocalization of Lucifer yellow (Fig. 5 B) with the internalized antibody (Fig. 5 A) , indicating that in MDCK cells part of the mutant receptor is present in endosomal structures and also reaches the basolateral plasma membrane.
The Transcytotic Movement of Anti-SC Antibody
We examined next whether the wild-type plgR in the dendritic early endosomes would be transcytosed to the axonal domain. For that purpose we bound fluorescently labeled anti-SC antibody at 4°C at 3 h postinfection and analyzed its distribution immediately thereafter or after allowing internalization at 36.5°C for 2 h (see Materials and Methods and Fig. 6 A) . In this way, we only look at the plgR that had reached the dendritic plasma membrane at this short postinfection time, and we thus avoid the interfering visualization of newly synthesized receptor. Directly after antibody binding, an intense uniform labeling was observed at the surface of the cell body and dendrites, but not at the axons (Fig. 7, A-C) . After 2 h at 36.5°C, the staining pattern was vesicular and the axon was now intensively labeled (Fig. 7, D-F) . These results show the change in the distribution of the receptor from the dendritic surface to the axonal domain. Using a similar experimental paradigm, we did not detect a change in distribution of A655-668 plgR, from axonal to dendritic, suggesting lack of trancytosis of the mutant receptor. In addition, we were also unable to observe a change in the distribution of mutated plgR upon the addition of the dlgA (data not shown), which increases axonal labeling of the wild-type receptor (Ikonen et al., 1993) .
Transcytosis Is Inhibited by BFA and Stimulated by PMA
The basolateral to apical transcytosis in MDCK cells is inhibited by the fungal metabolite BFA (Hunziker et al., 1991 (Hunziker et al., , 1992 . To investigate whether transcytosis in hippocampal neurons is regulated by a similar mechanism, we analyzed the effect of BFA on the dendro-axonal transcytosis of plgR. Infected neurons were incubated for 30 min at 4°C with FITC-labeled anti-SC at the end of the 3-h postinfection period, excess unbound antibody removed and the cells warmed at 36.5°C for 2 h in the presence or absence of 10 Ixg/ml BFA (see Fig. 6 B) . The results of these experiments are shown in Fig. 8 A. In the absence of BFA more than 50% of the infected neurons showed axonal anti-SC labeling at the end of the experiment. In the presence of BFA, on the contrary, axonal labeling did not occur and most cells retained the anti-SC labeling in the dendrites. The small percentage of cells with axonal labeling after BFA treatment was comparable to the percentage of axonal labeling observed at 3 h postinfection, before transcytosis was allowed to occur. These results show, similarly to the transcytosis of plgR in MDCK cells, the inhibitory effect of BFA in neuronal dendro-axonal transcytosis.
Recently it was shown that transcytosis of the plgR in MDCK cells is stimulated by phorbol esters (Cardone et al., 1994) . Using the assay described above, we tested if the phorbol ester PMA would increase axonal transcytosis of the plgR. Anti-SC binding at 4°C was followed by a short incubation (20 min) at 36.5°C in the presence or absence of 2 txM PMA (see Fig. 6 C) . At this short time after anti-SC binding, no significant axonal labeling was observed in the . At this time, most of the wildtype receptor is observed in the somato-dendritic domain (see Fig. 3 ). At the end of the labeling excess antibody is removed and the cells are either fixed or further incubated at 36.5°C for 2 h to allow the dendro-axonal movement of the labeled plgR (Fig. 6  A) and fixed at the end of this incubation period. Fixed cells are permeabilized to visualize the dendrites using antibodies against MAP2. To analyze the effect of BFA or PMA on transcytosis, these drugs were added during the incubation period after the labeling of the cells with FITC-bound antibodies. Incubations with BFA lasted 2 h (Fig. 6 B) , incubation in the presence of PMA only 20 min (Fig. 6 C) .
absence of PMA. However, PMA induced a rapid redistribution of the receptor from the dendritic to the axonal domain; the number of cells with axonal labeling increased about fourfold compared to control cells (Fig. 8 B) . This dramatic increase shows that in neuronal cells, like in MDCK cells, PKC stimulates the axonal appearance of wild-type pIgR.
Intracellular Routing of Wild-Type andA655-668 pIgR in Immature Hippocampal Neurons
After 2-3 d in culture hippocampal neurons acquire morphological polarity; one axon and several short neurites ("stage 3 cells"; Dotti et al., 1988) . We tested whether wild-type and the mutant A655-668 pIgR were sorted in a polarized fashion in these cells. Stage 3 neurons were infected with the recombinant viruses, fixed at 3 h postinfection and the distribution of the expressed receptors was analyzed by immunofluorescence microscopy (Fig. 9) . In contrast to fully mature neurons ("stage 5 cells"), fixed at the same postinfection time, no selective delivery of pIgR receptors to any processes was observed in stage 3 cells.
Discussion
Direct Sorting of Wild-Type and Mutant plgR in Hippocampal Neurons
In MDCK cells, membrane proteins are sorted in the transGolgi network into distinct vesicles destined for either the apical or the basolateral plasma membrane (WandingerNess et al., 1990) . In polarized neurons, membrane proteins are sorted to the axonal and to the dendritic surfaces (for a review see Craig and Banker, 1994) . In most cases membrane proteins, targeted to the apical surface of MDCK cells, are delivered to the axonal surface of neurons, whereas those with a basolateral fate in MDCK cells are delivered to the dendritic surface of neurons (for reviews see Rodriguez-Boulan and Powell, 1992; de Hoop and Dotti, 1993; Craig and Banker, 1994) . In MDCK cells, the wild-type pIgR is delivered to the basolateral membrane whereas the mutant pIgR is preferentially delivered to the apical membrane (Mostov, 1993; Casanova et al., 1991) . Using the SFV-expression system in cultured rat hippocampal neurons, we observed a dendritic distribution of the wild-type receptor and axonal distribution of mutated receptor at 3 h postinfection, the earliest time at which any expression is detectable. This strengthens the case for homologous sorting mechanisms in epithelial and neuronal cells. Although we are analyzing the distribution of a heterologous protein in neurons, endogenous proteins expressed via the SFV system are appropriately sorted and distributed to the right compartments (Olkkonen et al., 1993; de Hoop et al., 1994; Simons et al., 1995) . We therefore infer that the distribution of the pIgR at the earliest postinfection time reflects the domain to which direct sorting has taken place.
The Distribution of Wild-Type pIgR Changes at Longer Postinfection Times
With longer expression times, increasing amounts of the receptors were observed in the opposite domain; wild-type receptor appeared in the axons and the A655-668 mutant was detected in the dendrites. This change in distribution could be due to either transcytosis or missorting. We favor the idea that the late axonal appearance of the wild-type receptor is partly due to transcytosis. First, using an antibody binding and internalization assay, we noticed that wild-type receptors could migrate from dendrites to axons. Second, the labeling of axons was prevented by BFA and stimulated by PMA. Our previous results showing an increase of axonal pIgR upon addition of dIgA (Ikonen et al., 1993) further supports dendro-axonal transcytosis of pIgR. On the contrary, we consider the presence of the mutant receptor in the dendrites to be the consequence of missorting. Neither could we detect any change in intracellular distribution in the transcytosis assay nor had the addition of ligand any effect. The same mutant receptor expressed in MDCK cells does not transcytose (Casanova et al., 1991) . In these cells, although most of the mutant protein is delivered apically, ~5 % of the protein is detected on the basolateral surface (Casanova et al., 1991) , also suggesting missorting. We found that in MDCK cells, part of the A665-668 receptor can internalize anti-SC antibody from the basolateral surface to the basolateral early endosomes.
Neuronal Transcytosis of Wild-Type plgR Is Sensitive to BFA and PMA
Transcytosis of the polymeric immunoglobulin receptor in M D C K cells appears to be sensitive to protein kinase C (stimulated via PMA) (Cardone et al., 1994) and brefeldin A (BFA) (Hunziker et al., 1992) . We analyzed the effect of the compounds B F A and P M A to determine whether transcytosis of the pIgR in neurons was affected in a way similar to M D C K cells. With our transcytosis assay we found that B F A inhibited the axonal migration of receptor that had been fluorescently labeled at the dendritic surface. In the presence of PMA, transcytosis from the dendrites to the axon was accelerated. This increase in axonal labeling could be observed in times as short as 20 min. Thus, these experiments suggest that the transcytotic pathway in neurons resembles that of M D C K cells; in the sense that it is inhibited by B F A and stimulated by PMA. Treatment of hippocampal neurons with B F A induces endosomal tubulation without affecting the uptake of fluid-phase ligands . Therefore, as in M D C K cells (Hunziker et al., 1991) , B F A might block the dendroaxonal transcytosis of pIgR by specifically affecting the formation of transcytotic vesicles in the early endosomes. Whether B F A also affects the transport to the degradative compartment and/or the recycling to the plasma membrane in neurons is not known. In M D C K cells, however, B F A does not affect these pathways (Hunziker et al., 1991) . In M D C K cells P M A increases the movement of pIgR from the apical endosomes to the apical surface and accelerates the rate of transcytosis from the basolateral endosomes (Cardone et al., 1994) . Although we did not determine the effect of P M A on the release of IgA from the axonal endosomes, our work clearly shows that in neurons P M A increases dendro-axonal transcytosis by accelerating the migration of pIgR from the dendritic early endosomes or from the dendritic plasma membrane to the axonal domain. It is believed that the effect of P M A on M D C K cells to stimulate transcytosis mimics the action of cholinergic agonsits to stimulate the release of IgA by nasal and intestinal epithelia in vivo (Raphael et al., 1988; Freier et al., 1987; Wilson et al., 1992) . Since hippocampal neurons in culture also appear to respond to P M A by increasing the rate of transcytosis, we envision that in vivo neurons may regulate the traffic of endogenous transcytosed molecules in response to different hormones and neurotransmitters.
Sorting of the pIgR Is Developmentally Regulated
In stage 3 hippocampal neurons morphological polarization is already visible, the longer neurite will develop into the futural axon (Dotti et al., 1988) . This polarity is however not yet fixed; amputation of the futural axon results in the acquisition of axonal properties of one of the other neurites and the acquisition of dendritic properties of the amputated axon (Dotti and Banker, 1987; Goslin and Banker, 1989) . Expression of either wild-type or mutant pIgR in stage 3 hippocampal neurons, led to the nonpolarized distribution of the receptor. Accordingly, certain Both the wild-type as well as the A655-668 plgR could be observed in the small neurites that will form the dendrites (small arrows) as well as in the longer outgrowing neurite that will from the axon (large arrows). Bar, 20 ixm. endogenous proteins, with polarized distribution in fully differentiated stage 5 hippocampal neurons, are evenly distributed in the stage 3 cells, despite their morphological polarity (Killisch et al., 1991; Craig et al., 1993; van Lookeren Campagne et al., 1992; Huber et al., 1993b ; see however, Goslin et al., 1990 and Fletcher et al., 1991) . Similarly, viral glycoproteins expressed in differentiated neurons are sorted to the axon or the dendrites of fully mature (stage 5) neurons, whereas the same proteins are not sorted in morphologically polarized stage 3 neurons (Dotti and Simons, 1990 ). Altogether, these results suggest the asynchronous development of the machinery responsible for the establishment of morphological polarity and polarized protein delivery. The establishment of the machinery for molecular sorting is also a late occurring event in epithelial cells. Two different types of epithelial cells, MDCK and FRT, show lack of protein sorting at early developmental stages (Wollner et al., 1992; Zurzolo et al., 1992) . The mechanism which regulates the stabilization of neuronal polarity and molecular sorting remain to be identified.
Implications of Neuronal Transcytosis
Bearing in mind the similarities between epithelial MDCK cells and neurons, it was logical to hypothesize that neurons could make use of a dendro-axonal transcytotic route, either as a way to generate membrane asymmetry or to transport macromolecules. However, little is known about the existence of a transcellular vesicular transport pathway in neurons. Wheat germ agglutinin (WGA) has been shown to undergo dendritic to axonal transneuronal transport in retinal ganglion cells (LaVail and Margolis, 1987; Ruda and Coulter, 1982) . However, it may not use the same transcytotic pathway as the plgR. Unlike plgR, after dendritic uptake W G A accumulates in the Golgi apparatus of most cells, including hippocampal neurons (Dotti and Banker, 1991) . Therefore, the presence of W G A along vesicular profiles in axons of the visual system might represent exocytic rather than transcytotic vesicles. Horseradish peroxidase and fibroblast growth factor have also been shown to undergo anterograde transport in the optic nerve after uptake in the ganglion cells (Pickard and Silverman, 1981; Ferguson et al., 1990) , possibly by a transcytotic mechanism similar to that of the pfgR. There are also indications for a transneuronal axo-dendritic transport (Schwab and Thoenen, 1978; Schwab et al., 1979; Evinger and Erichsen, 1986; Fabian, 1991; Simons et al., 1995) .
Altogether our work reveals the existence of a transcytotic pathway in neurons and shows similarities of this pathway between epithelial and neuronal cells. To what extent transcytotic pathways are important for the establishment and maintenance of neuronal cell polarity or for transneuronal communication remains to be established. Transcytosis might be the pathway by which growth factors, like basic fibroblast growth factor, are transported during neuronal development (Ferguson et al., 1990) , and thus be an essential mode of transcellular communication.
In support of this are the observations that an axonal to dendritic transcytotic process might be involved in the generation of motor-neuron diseases and other neurological malfunctions (Fabian, 1991; LaRocca and Wiley, 1988) and that the amyloid precursor protein (APP) is transcytosed from axons to dendrites . However, the true in vivo physiological role of neuronal transcytosis remains to be identified.
